All lobbying filings

FARRAGUT PARTNERS LLP

Lobbying for GENENTECH · Biotechnology

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 1

Health Issues

Issues related to legislation relating to the 340B drug discount program. Also, legislation relating to Medicare physician payments, including H.R. 4299. Issues relating to GLOBE/GUARD

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.